Share this

Varicella Facts

EU/EEA, European Union / European Economic Area; GBD,Global Burden of Disease; UI,Uncertainty Interval


a Results from a systematic review, 44 studies were included consisting of 19 observational/retrospective studies, 21 cost-effectiveness studies and 4 studies with a mixed design (i.e., internet questionnaire, surveys, pooled analysis of several studies, health cost analysis). The selected studies were conducted in 22 countries, most of them in Europe (n = 28), followed by Asia and Middle East (n = 6), South America (n = 5) and North America (n = 3)

References

  1. Wu Z, Zhang J, Wei J, Huang C, Xu W, Wu J, Jiang M. Global burden of varicella and herpes zoster across 204 countries, 1990–2021: a temporal trend analysis in the era of the COVID-19 pandemic and projections to 2036. Frontiers in Public Health. 2025 Dec 5;13:1654535.
  2. World Health Organization (WHO). Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec. 2014; 89 (25): 265– 287.
  3. European Centre for Disease Prevention and Control. Varicella vaccination in the European Union. 2015. Accessed April 30, 2026. https://www.ecdc.europa.eu/en/publicationsdata/ public-health-guidance-varicella-vaccination-european-union
  4. Williame I, George M, Shah HA, Homer N, Alderson D, Jamet N. Healthcare resource use and costs of varicella and its complications: A systematic literature review. Human Vaccines & Immunotherapeutics. 2023 Dec 15;19(3):2266225

AE-VVX-00010 | Exp : 16 April 2028